Pfizer To Shut Two India Plants, 1,700 Employees To Be Impacted: Report
Business | Thomson Reuters | Wednesday January 9, 2019
Pfizer acquired the sites as part of its $15 billion purchase of Hospira in 2015, to boost its portfolio of generic injectable drugs and copies of biotech medicines.
GlaxoSmithKline To Split After Joint Venture Deal With Pfizer
Business | Thomson Reuters | Wednesday December 19, 2018
GSK and Pfizer would combine their consumer health businesses in a joint venture with sales of 9.8 billion pounds ($12.7 billion), 68 per cent-owned by the British company, in an all-equity transaction.
After Donald Trump Tweet, Drug Company Pfizer Reverses Price Hikes
World News | Reuters | Thursday July 12, 2018
Pfizer has reversed price increases on some drugs following White House pressure and the US drugmaker on Wednesday pledged to decide soon whether to sell its consumer drugs business.
Trump Says Drugmaker Pfizer Should Be "Ashamed" For Drug Price Hikes
World News | Reuters | Tuesday July 10, 2018
US President Donald Trump on Monday took aim at Pfizer Inc and other US drugmakers after they raised prices on some of their medicines on July 1, saying his administration would act in response.
Viagra Turns 20: Chronicle Of A Global Success
World News | Agence France-Presse | Monday March 26, 2018
Launched in the United States 20 years ago, Viagra has sold in the billions and become an unexpected source of revenue for its maker Pfizer, as well as copycats worldwide.
When Sensex Is Crashing, These Stocks Manage To Soar Upto 5%
Business | NDTV Profit Team | Tuesday February 6, 2018
Aegis, Bajaj Finance, Bajaj Electricals, Pfizer and NIIT rose by 3.53%, 3.48%, 2.77%, 2.71% and 2.65%, respectively on the BSE
UK Gives Pfizer World's First Over-The-Counter Viagra Approval
World News | Reuters | Wednesday November 29, 2017
Pfizer's big-selling erectile dysfunction drug Viagra has been given a green light for sale without a prescription in Britain, the first country to grant it over-the-counter status.
Pfizer Gets Pneumonia Vaccine Patent In Blow To Aid Group
Business | Thomson Reuters | Tuesday August 22, 2017
It's a big victory for the US drugmaker in a market that has the world's largest number of pneumonia cases.
Pfizer Jumps Over 7% On AstraZeneca Deal
Business | Press Trust of India | Thursday June 1, 2017
Pfizer entered into a pact with AstraZeneca AB to acquire the 'Neksium' brand in India for Rs 75 crore.
Britain Fines Pfizer Record $107 Million For Huge Drug Price Hike
World News | Reuters | Wednesday December 7, 2016
Britain's competition watchdog said on Wednesday it had fined Pfizer a record 84.2 million pounds ($106.54 million) for ramping up the cost of an epilepsy drug by as much as 2,600 percent.
Britain Fines Pfizer Record $107 Mfor Huge Drug Price Hike
Business | Thomson Reuters | Wednesday December 7, 2016
The Competition and Markets Authority also fined Flynn Pharma 5.2 million pounds for its role in hiking prices of phenytoin sodium capsules in 2012.
Pfizer Withdraws Corex Syrup, Extends Line To New Products
India News | Press Trust of India | Tuesday November 29, 2016
Drug maker Pfizer is planning to extend its Corex brand to a series of new products to treat respiratory ailments as part of a revamp of its product portfolio.
Pfizer Withdraws Corex Syrup, Extends Line To New Products
Business | Press Trust of India | Tuesday November 29, 2016
The company has also decided to discontinue the manufacturing of current Corex cough syrup formulation.
Just Dial, Pfizer To Be Dropped From BSE 200; Muthoot Finance In
Business | Press Trust of India | Friday November 18, 2016
The changes are announced by Asia Index, a joint venture between S&P Dow Jones Indices LLC and BSE.
Big Pharma Vs Big Pharma In Court Battles Over Biosimilar Drugs
Business | Thomson Reuters | Sunday October 2, 2016
Biologics, manufactured in living cells, then extracted and purified, are more complex than traditional medicines and cannot be copied with precision, and so their knock-off versions are called biosimilars instead of generics.
Drug Ban: What's Safe For Us?
Mar 17, 2016
Government Crackdown On 'Mix-And-Match' Drugs
Mar 14, 2016
Corex, Popular Cough Syrup, Not Banned For Now, Says Court
Mar 14, 2016
Need Regulations to Deal With Unfair Medical Practices: Kewal Handa
Sep 23, 2015
Faster ANDA Approval
Mar 20, 2015
Drugs in India Available at Cheap Prices: Kewal Handa
Sep 24, 2014
Pharma companies need improve quality standards: Pfizer
May 27, 2013
Strong growth in domestic formulations business: ALEMBIC
May 7, 2013
Pharma pricing policy a step in the right direction: Kewal Handa
Nov 22, 2012
Pfizer To Shut Two India Plants, 1,700 Employees To Be Impacted: Report
Business | Thomson Reuters | Wednesday January 9, 2019
Pfizer acquired the sites as part of its $15 billion purchase of Hospira in 2015, to boost its portfolio of generic injectable drugs and copies of biotech medicines.
GlaxoSmithKline To Split After Joint Venture Deal With Pfizer
Business | Thomson Reuters | Wednesday December 19, 2018
GSK and Pfizer would combine their consumer health businesses in a joint venture with sales of 9.8 billion pounds ($12.7 billion), 68 per cent-owned by the British company, in an all-equity transaction.
After Donald Trump Tweet, Drug Company Pfizer Reverses Price Hikes
World News | Reuters | Thursday July 12, 2018
Pfizer has reversed price increases on some drugs following White House pressure and the US drugmaker on Wednesday pledged to decide soon whether to sell its consumer drugs business.
Trump Says Drugmaker Pfizer Should Be "Ashamed" For Drug Price Hikes
World News | Reuters | Tuesday July 10, 2018
US President Donald Trump on Monday took aim at Pfizer Inc and other US drugmakers after they raised prices on some of their medicines on July 1, saying his administration would act in response.
Viagra Turns 20: Chronicle Of A Global Success
World News | Agence France-Presse | Monday March 26, 2018
Launched in the United States 20 years ago, Viagra has sold in the billions and become an unexpected source of revenue for its maker Pfizer, as well as copycats worldwide.
When Sensex Is Crashing, These Stocks Manage To Soar Upto 5%
Business | NDTV Profit Team | Tuesday February 6, 2018
Aegis, Bajaj Finance, Bajaj Electricals, Pfizer and NIIT rose by 3.53%, 3.48%, 2.77%, 2.71% and 2.65%, respectively on the BSE
UK Gives Pfizer World's First Over-The-Counter Viagra Approval
World News | Reuters | Wednesday November 29, 2017
Pfizer's big-selling erectile dysfunction drug Viagra has been given a green light for sale without a prescription in Britain, the first country to grant it over-the-counter status.
Pfizer Gets Pneumonia Vaccine Patent In Blow To Aid Group
Business | Thomson Reuters | Tuesday August 22, 2017
It's a big victory for the US drugmaker in a market that has the world's largest number of pneumonia cases.
Pfizer Jumps Over 7% On AstraZeneca Deal
Business | Press Trust of India | Thursday June 1, 2017
Pfizer entered into a pact with AstraZeneca AB to acquire the 'Neksium' brand in India for Rs 75 crore.
Britain Fines Pfizer Record $107 Million For Huge Drug Price Hike
World News | Reuters | Wednesday December 7, 2016
Britain's competition watchdog said on Wednesday it had fined Pfizer a record 84.2 million pounds ($106.54 million) for ramping up the cost of an epilepsy drug by as much as 2,600 percent.
Britain Fines Pfizer Record $107 Mfor Huge Drug Price Hike
Business | Thomson Reuters | Wednesday December 7, 2016
The Competition and Markets Authority also fined Flynn Pharma 5.2 million pounds for its role in hiking prices of phenytoin sodium capsules in 2012.
Pfizer Withdraws Corex Syrup, Extends Line To New Products
India News | Press Trust of India | Tuesday November 29, 2016
Drug maker Pfizer is planning to extend its Corex brand to a series of new products to treat respiratory ailments as part of a revamp of its product portfolio.
Pfizer Withdraws Corex Syrup, Extends Line To New Products
Business | Press Trust of India | Tuesday November 29, 2016
The company has also decided to discontinue the manufacturing of current Corex cough syrup formulation.
Just Dial, Pfizer To Be Dropped From BSE 200; Muthoot Finance In
Business | Press Trust of India | Friday November 18, 2016
The changes are announced by Asia Index, a joint venture between S&P Dow Jones Indices LLC and BSE.
Big Pharma Vs Big Pharma In Court Battles Over Biosimilar Drugs
Business | Thomson Reuters | Sunday October 2, 2016
Biologics, manufactured in living cells, then extracted and purified, are more complex than traditional medicines and cannot be copied with precision, and so their knock-off versions are called biosimilars instead of generics.
Drug Ban: What's Safe For Us?
Mar 17, 2016
Government Crackdown On 'Mix-And-Match' Drugs
Mar 14, 2016
Corex, Popular Cough Syrup, Not Banned For Now, Says Court
Mar 14, 2016
Need Regulations to Deal With Unfair Medical Practices: Kewal Handa
Sep 23, 2015
Faster ANDA Approval
Mar 20, 2015
Drugs in India Available at Cheap Prices: Kewal Handa
Sep 24, 2014
Pharma companies need improve quality standards: Pfizer
May 27, 2013
Strong growth in domestic formulations business: ALEMBIC
May 7, 2013
Pharma pricing policy a step in the right direction: Kewal Handa
Nov 22, 2012
................................ Advertisement ................................
................................ Advertisement ................................
